<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251202068189N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-28</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Hyaluronic Acid on stiffness of wrist</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effect of Intra-Articular Hyaluronic Acid Injection on Postoperative Stiffness in Patients with Distal Radius Fractures Treated with Volar Plate Fixation (ORIF): A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87854</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Eligible patients, after providing informed consent, are randomly assigned to the intervention or control groups using block randomization with a 1:1 allocation ratio. The unit of randomization is the individual patient, and no stratified randomization is applied.
The random sequence is generated using statistical software based on blocks of variable size to minimize predictability of group assignment.
Allocation concealment is ensured by using sequentially numbered, opaque, sealed envelopes containing the group allocation codes, which are opened only after completion of surgery and wound closure, thereby minimizing selection bias, Blinding description: In this study, participants (patients) are blinded to their group allocation.
Outcome assessors, including physiotherapists and personnel responsible for measuring range of motion, pain scores, and functional outcomes, are blinded to group assignment.
The statistical analyst performs data analysis using anonymized group codes and is not aware of the treatment allocation.
Due to the nature of the intervention, the operating surgeon is aware of the group assignment at the time of intervention; however, the surgeon has no role in outcome assessment, data collection, or statistical analysis.
All participants are fully informed about their participation in the study, and written informed consent is obtained; lack of patient awareness of study participation is not involved.</study_design>
      <phase>3</phase>
      <hc_freetext>Postoperative joint stiffness, distal radius fracture, limitation of wrist range of motion.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention Group (HA group): Patients will receive a single 2 mL intra-articular injection of hyaluronic acid (e.g., sodium hyaluronate 20 mg/2 mL) after wound closure. Intervention 2: Control Group: Patients will receive no injection and standard postoperative care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Title of shared documents: De-identified raw dataset of primary and secondary outcome measures.
Details: Individual participant data will be shared only after complete removal of all identifiable information (including names, national identification numbers, and hospital record numbers). The shared dataset will include wrist range-of-motion measurements, pain scores, functional questionnaire results, and postoperative complication records. Data will be provided exclusively in a fully de-identified format and only for research purposes, upon formal request and approval by the ethics committee

When:
Access to the shared dataset will begin six months after publication of the final study results and will remain available for at least three years thereafter

To whom:
Requests for access to the study data may be submitted only by researchers and academic investigators affiliated with recognized universities or research institutions. Applicants must present a clearly defined scientific purpose and obtain ethics committee approval. Data will not be shared with individuals or organizations seeking access for commercial or industrial purposes

Conditions:
Access to de-identified data will be granted only if the applicant provides a defined research proposal, clear scientific objectives, and an appropriate analysis plan. Use of the data is restricted to academic and statistical research purposes only. Commercial use, promotional use, or redistribution of the dataset is strictly prohibited. Applicants must sign a confidentiality agreement and are permitted to use the dataset solely within the scope of the ethics-approved research protocol. Further sharing of the dataset with third parties without written permission is not allowed

Where to obtain:
Applicants who wish to obtain the study data or related documentation may submit their official request primarily via email, followed by telephone contact if needed.
The designated contact person for responding to data requests is Dr. Ebrahim Khazaee.
Email addresses for correspondence:
E-khazaee@student.tums.ac.ir

khazaei70@yahoo.com

Telephone number: +989156210690
If in-person or postal correspondence becomes necessary, arrangements will be made through the above email addresses and the postal address will be provided accordingly. Applicants must submit a clear research objective and a relevant study proposal along with their request

How to obtain:
The process for obtaining the requested dataset consists of several steps. Applicants must first submit an official request via email, including their research objective and study proposal. The request will be reviewed within 7–14 business days, and additional clarification may be requested if needed. Following initial approval, the request will be evaluated for ethical compliance, which typically requires 14–30 business days. After final approval, the de-identified dataset will be provided within 14 business days through a secure email or restricted access link. Overall, the estimated time required to receive the dataset ranges from 4 to 8 weeks, depending on administrative processing time and applicant responsiveness

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ibrahim Alkhuzaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.239, between Gisha St. 36 and 38</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1448933137</zip>
        <telephone>+98 915 621 0690</telephone>
        <email>khazaei70@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Omid Salkhori</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini Hospital Complex, Keshavarz Boulevard, Chamran Highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۹۷۳۳۱۴۱</zip>
        <telephone>+98 922 483 8234</telephone>
        <email>omidsalkhorii303@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adults aged 18 to 70 years
Acute, closed distal radius fracture requiring ORIF with volar plate
Ability and willingness to provide written informed consent and adhere to the follow-up schedule</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Open or pathological fractures
Previous surgery or trauma to the affected wrist
Systemic inflammatory joint disease (e.g., rheumatoid arthritis)
Known allergy to Hyaluronic Acid or its components
Local or systemic infection
Inability to participate in rehabilitation or follow-up
Intraarticular fracture</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M25.63</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stiffness of wrist, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention Group (HA group): Patients will receive a single 2 mL intra-articular injection of hyaluronic acid (e.g., sodium hyaluronate 20 mg/2 mL) after wound closure.</i_keyword>
      <i_keyword>Control Group: Patients will receive no injection and standard postoperative care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Wrist range of motion (flexion–extension), measured using a goniometer by a blinded assessor at 12 weeks post-operation. Timepoint: Wrist flexion–extension ROM will be measured at week 6 and at week 12 after surgery. Method of measurement: Wrist joint range of motion will be measured using a standard goniometer by a trained and blinded assessor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain intensity measured using the Visual Analogue Scale by a blinded assessor at weeks two, six, and twelve after surgery. Timepoint: Pain intensity measured at weeks two, six, and twelve after surgery. Method of measurement: Visual Analogue Scale by a blinded assessor.</sec_outcome>
      <sec_outcome>Wrist functional status measured using the Quick Disabilities of the Arm, Shoulder and Hand questionnaire at weeks six and twelve after surgery. Timepoint: at weeks six and twelve after surgery. Method of measurement: the Quick Disabilities of the Arm, Shoulder and Hand questionnaire at weeks six and twelve after surgery.</sec_outcome>
      <sec_outcome>Postoperative complications including persistent joint stiffness, joint swelling, and infection assessed up to week twelve after surgery. Timepoint: up to week twelve after surgery. Method of measurement: Postoperative complications including persistent joint stiffness, joint swelling, and infection will be assessed through clinical examination by the treating physician and documented using a standard clinical evaluation checklist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-30</approval_date>
        <contact_name>Ethics Committee of Imam Khomeini Hospital Complex – Tehran University of Medical Sciences</contact_name>
        <contact_address>Imam Khomeini Hospital Complex, Keshavarz Boulevard, Chamran Highway, Tehran, Iran tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
